sk-co-1 (CancerTools Org)
CancerTools Org is a verified supplier 
CancerTools Org manufactures this product 
99
Structured Review
CancerTools Org
sk-co-1
Sk Co 1, supplied by CancerTools Org, used in various techniques. Bioz Stars score: 99/100, based on 290 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sk-co-1/SK-CO-1/custom%40161933%4042640371
Average 99 stars, based on 290 article reviews
Sk Co 1, supplied by CancerTools Org, used in various techniques. Bioz Stars score: 99/100, based on 290 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sk-co-1/SK-CO-1/custom%40161933%4042640371
Average 99 stars, based on 290 article reviews
sk-co-1 - by Bioz Stars,
2026-09
99/100 stars
Images
Related Articles
Activity Assay:Article Title: Exceptional treatment responses and molecular markers among 103 colorectal cancer cell lines. Article Snippet: alidity of the approach. This included FGFR inhibitors in the cell line NCI-H716, an ALK inhibitor in C10, and a PORCN inhibitor in SNU-1411 (Fig. S5a-c) [20, 24]. Furthermore, the cell lines KM12 and Mutagenesis:Article Title: Exceptional treatment responses and molecular markers among 103 colorectal cancer cell lines. Article Snippet: alidity of the approach. This included FGFR inhibitors in the cell line NCI-H716, an ALK inhibitor in C10, and a PORCN inhibitor in SNU-1411 (Fig. S5a-c) [20, 24]. Furthermore, the cell lines KM12 and Invasion Assay:Article Title: Exceptional treatment responses and molecular markers among 103 colorectal cancer cell lines. Article Snippet: alidity of the approach. This included FGFR inhibitors in the cell line NCI-H716, an ALK inhibitor in C10, and a PORCN inhibitor in SNU-1411 (Fig. S5a-c) [20, 24]. Furthermore, the cell lines KM12 and Enzyme-linked Immunosorbent Assay:Article Title: Exceptional treatment responses and molecular markers among 103 colorectal cancer cell lines. Article Snippet: alidity of the approach. This included FGFR inhibitors in the cell line NCI-H716, an ALK inhibitor in C10, and a PORCN inhibitor in SNU-1411 (Fig. S5a-c) [20, 24]. Furthermore, the cell lines KM12 and Migration:Article Title: Exceptional treatment responses and molecular markers among 103 colorectal cancer cell lines. Article Snippet: alidity of the approach. This included FGFR inhibitors in the cell line NCI-H716, an ALK inhibitor in C10, and a PORCN inhibitor in SNU-1411 (Fig. S5a-c) [20, 24]. Furthermore, the cell lines KM12 and Expressing:Article Title: Exceptional treatment responses and molecular markers among 103 colorectal cancer cell lines. Article Snippet: alidity of the approach. This included FGFR inhibitors in the cell line NCI-H716, an ALK inhibitor in C10, and a PORCN inhibitor in SNU-1411 (Fig. S5a-c) [20, 24]. Furthermore, the cell lines KM12 and Inhibition:Article Title: Exceptional treatment responses and molecular markers among 103 colorectal cancer cell lines. Article Snippet: alidity of the approach. This included FGFR inhibitors in the cell line NCI-H716, an ALK inhibitor in C10, and a PORCN inhibitor in SNU-1411 (Fig. S5a-c) [20, 24]. Furthermore, the cell lines KM12 and Cell Isolation:Article Title: Exceptional treatment responses and molecular markers among 103 colorectal cancer cell lines. Article Snippet: alidity of the approach. This included FGFR inhibitors in the cell line NCI-H716, an ALK inhibitor in C10, and a PORCN inhibitor in SNU-1411 (Fig. S5a-c) [20, 24]. Furthermore, the cell lines KM12 and Cell Culture:Article Title: Exceptional treatment responses and molecular markers among 103 colorectal cancer cell lines. Article Snippet: alidity of the approach. This included FGFR inhibitors in the cell line NCI-H716, an ALK inhibitor in C10, and a PORCN inhibitor in SNU-1411 (Fig. S5a-c) [20, 24]. Furthermore, the cell lines KM12 and Drug discovery:Article Title: Exceptional treatment responses and molecular markers among 103 colorectal cancer cell lines. Article Snippet: alidity of the approach. This included FGFR inhibitors in the cell line NCI-H716, an ALK inhibitor in C10, and a PORCN inhibitor in SNU-1411 (Fig. S5a-c) [20, 24]. Furthermore, the cell lines KM12 and Isolation:Article Title: Exceptional treatment responses and molecular markers among 103 colorectal cancer cell lines. Article Snippet: alidity of the approach. This included FGFR inhibitors in the cell line NCI-H716, an ALK inhibitor in C10, and a PORCN inhibitor in SNU-1411 (Fig. S5a-c) [20, 24]. Furthermore, the cell lines KM12 and Reverse Transcription Polymerase Chain Reaction:Article Title: Exceptional treatment responses and molecular markers among 103 colorectal cancer cell lines. Article Snippet: alidity of the approach. This included FGFR inhibitors in the cell line NCI-H716, an ALK inhibitor in C10, and a PORCN inhibitor in SNU-1411 (Fig. S5a-c) [20, 24]. Furthermore, the cell lines KM12 and Quantitative RT-PCR:Article Title: Exceptional treatment responses and molecular markers among 103 colorectal cancer cell lines. Article Snippet: alidity of the approach. This included FGFR inhibitors in the cell line NCI-H716, an ALK inhibitor in C10, and a PORCN inhibitor in SNU-1411 (Fig. S5a-c) [20, 24]. Furthermore, the cell lines KM12 and |